Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
Joint Authors
Mirza, Muhammad
Mirza, Maira
Murugesan, Vagishwari
Olano, Arrel
Source
Case Reports in Gastrointestinal Medicine
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-11-06
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract.
Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades.
Infliximab is known to be associated with various adverse effects including anti-TNF alpha induced lupus (ATIL).
We present a rare case of a 51-year-old female with pericardial effusion secondary to infliximab therapy for treatment of her ulcerative colitis.
Discontinuation of infliximab led to resolution of the pericardial effusion.
American Psychological Association (APA)
Mirza, Muhammad& Mirza, Maira& Murugesan, Vagishwari& Olano, Arrel. 2018. Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis. Case Reports in Gastrointestinal Medicine،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1143474
Modern Language Association (MLA)
Mirza, Muhammad…[et al.]. Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis. Case Reports in Gastrointestinal Medicine No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1143474
American Medical Association (AMA)
Mirza, Muhammad& Mirza, Maira& Murugesan, Vagishwari& Olano, Arrel. Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis. Case Reports in Gastrointestinal Medicine. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1143474
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1143474
